Lamictal

Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antiepileptic Drugs: A Systematic Review

A systematic review examines neurodevelopmental outcomes in children prenatally exposed to antiepileptic drugs.

By |2025-06-26T09:07:20-04:00May 1st, 2024|Anti-Epileptic Drugs, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications|Comments Off on Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antiepileptic Drugs: A Systematic Review

Reassuring News: Neurodevelopmental Outcomes in Two-Year Olds with Prenatal Exposure to Lamotrigine (Lamictal)

These findings are encouraging and suggest that the newer AEDs, specifically lamotrigine and levetiracetam, are not associated with worse neurodevelopmental outcomes.

By |2025-06-26T09:06:51-04:00February 9th, 2022|Pregnancy & Medications|Comments Off on Reassuring News: Neurodevelopmental Outcomes in Two-Year Olds with Prenatal Exposure to Lamotrigine (Lamictal)

Clinical Update 2020: Lamotrigine (Lamictal) and Pregnancy

Clinical Update 2020:  Lamotrigine (Lamictal) and Pregnancy Maintenance treatment with a mood stabilizer during pregnancy can significantly reduce the risk of relapse in women with bipolar disorder; however, many of the mood stabilizers commonly [...]

By |2025-06-26T09:06:58-04:00July 28th, 2020|Anti-Epileptic Drugs, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Clinical Update 2020: Lamotrigine (Lamictal) and Pregnancy

You Asked: Should Women Taking Lamotrigine (Lamictal) Use Higher Dose of Folic Acid When Planning for Pregnancy?

We have really enjoyed our weekly virtual rounds.  It’s been a great opportunity to meet other perinatal psychiatrists in the community, and discussions with new people always brings up interesting clinical questions.  Last week [...]

By |2025-06-26T09:06:59-04:00May 20th, 2020|Anti-Epileptic Drugs, Pregnancy & Medications, Treatment, You Asked|Comments Off on You Asked: Should Women Taking Lamotrigine (Lamictal) Use Higher Dose of Folic Acid When Planning for Pregnancy?

Lithium and Anticonvulsant Mood Stabilizers: No Higher Risk for Adverse Pregnancy Outcomes

For women with bipolar disorder, choosing whether to maintain or discontinue treatment with a mood stabilizer during pregnancy is challenging.  This is a process which requires careful and thoughtful consideration, weighing the risk of adverse [...]

By |2025-06-26T09:07:40-04:00August 5th, 2019|Pregnancy & Medications|Comments Off on Lithium and Anticonvulsant Mood Stabilizers: No Higher Risk for Adverse Pregnancy Outcomes

Behavior Problems More Common In Children with Prenatal Exposure to Valproic Acid

While we have considerable information regarding the teratogenic risk associated with prenatal exposure to various antiepileptic (AED) drugs, we have less impact on exposure to AEDs on behavior outcomes in children.  Several studies have shown [...]

By |2025-06-26T09:07:41-04:00July 15th, 2019|Anti-Epileptic Drugs, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications|Comments Off on Behavior Problems More Common In Children with Prenatal Exposure to Valproic Acid

Lamotrigine and Pregnancy: Meta-Analysis Shows No Increase in Risk for Malformations

  Maintenance treatment with a mood stabilizer during pregnancy can significantly reduce the risk of relapse in women with bipolar disorder; however, many of the mood stabilizers commonly used in this setting, including lithium and [...]

By |2025-06-26T09:07:02-04:00May 8th, 2017|Anti-Epileptic Drugs, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Lamotrigine and Pregnancy: Meta-Analysis Shows No Increase in Risk for Malformations
Go to Top